Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Summary of Stock Plan Activity

Summaries of the Company’s 2018 Stock Plan activity for the three months ended March 31, 2023 is presented below.

	Options Outstanding
	Number of Options			Weighted- Average Exercise Price ($ per share)		Weighted Average Remaining Contractual Life (years)		Aggregate Intrinsic Value
December 31, 2022		9,671		$	0.67		6.99	$	18,234
Granted		3,070		$	2.87
Exercised		(151	)	$	0.47
March 31, 2023		12,590		$	1.21		7.50	$	19,061
Exercisable options as of March 31, 2023		8,360		$	0.55		6.61	$	17,063

Summary of Restricted Stock Units Activity

The table below summarizes the activity related to the RSUs.

	Restricted Stock Units
	Number of Restricted Stock Units			Weighted Average Grant Date Fair Value (per share)
December 31, 2022		5,493		$	5.43
Granted		2,241		$	2.86
Vested or distributed		(751	)	$	6.06
Forfeited		(177	)	$	3.98
March 31, 2023		6,806		$	4.55

Summary of Fair value of Stock Option Grants

The fair value of stock option grants is estimated by the Company on the date of grant using the Black Scholes-Merton option pricing model with the following weighted-average assumptions for the three months ended March 31, 2023 and 2022.

	As of March 31,
	2023			2022
Risk free interest		3.55	%		1.47	%
Dividend yield		0.00	%		0.00	%
Expected volatility		75.00	%		58.80	%
Expected life (years)		6.08			6.08

Summary of Stock-based Compensation Expense

The Company recorded stock-based compensation expense as follows.

	For the three months ended March 31,
	2023		2022
Cost of revenue	$	251	$	-
Research and development		978		881
Sales and marketing		236		539
General and administrative		2,215		2,103
Total	$	3,680	$	3,523